No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Aromatase Inhibitors*
-
Breast Neoplasms / drug therapy*
-
Controlled Clinical Trials as Topic
-
Cross-Over Studies
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / therapeutic use*
-
Estrogen Receptor Modulators / therapeutic use
-
Female
-
Humans
-
Letrozole
-
Neoplasms, Hormone-Dependent / drug therapy*
-
Nitriles / therapeutic use
-
Survival Analysis
-
Tamoxifen / therapeutic use
-
Treatment Outcome
-
Triazoles / therapeutic use
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Enzyme Inhibitors
-
Estrogen Receptor Modulators
-
Nitriles
-
Triazoles
-
Tamoxifen
-
Letrozole